Nektar Therapeutics

NASDAQ: NKTR · Real-Time Price · USD
27.24
0.55 (2.06%)
At close: Aug 15, 2025, 3:59 PM
26.80
-1.62%
After-hours: Aug 15, 2025, 07:25 PM EDT

Nektar Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-122.27M -133.04M -118.96M -168.3M -177.08M -175.84M -276.06M -293.67M -306.88M -414.82M -368.2M -454.15M -524.81M -491.26M -523.84M -495.39M -474.27M -428.76M
Depreciation & Amortization
-6.62M -4.5M -3.32M -2M 6.41M 7.12M 7.82M 9.35M 10.33M 11.6M 13.03M 13.28M 14.23M 14.33M 14.15M 13.96M 13.58M 13.22M
Stock-Based Compensation
17.58M 19.51M 21.61M 24.06M 26.82M 29.37M 33.39M 38.87M 43.24M 46.38M 57.32M 66.99M 79.13M 91.74M 94.67M 94.26M 93.27M 92.92M
Other Working Capital
-26.62M -16.11M -11.63M -10.57M -10.28M -29.91M -22.39M -29.91M -41.65M -29.09M -15.72M -35.89M -24.97M -13.21M -23.27M 9.22M 44.26M 4.9M
Other Non-Cash Items
-54.16M -53.84M -63.52M -27.3M -27.59M -25.96M 63.14M 65.42M 55.79M 104.94M -9.36M 18.93M 30.87M -18.91M 17.41M -11.89M -12.63M -11.05M
Deferred Income Tax
-19K 38K n/a 1.7M 1.72M 1.63M -140K 854K 869K 896K 2.71M 383K 3.71M 6.42M 8.02M 7.64M 4.31M 1.6M
Change in Working Capital
-19.42M -5.04M -11.52M -4.73M -5.04M -24.9M -20.75M -24.09M -47.37M -16.49M 492K -43.27M -19.21M -26.32M -23.08M 31.68M 64.46M 19.76M
Operating Cash Flow
-184.91M -176.87M -175.71M -176.57M -174.76M -188.58M -192.61M -203.26M -244.03M -267.5M -304.01M -397.84M -416.09M -424M -412.66M -359.76M -311.3M -312.3M
Capital Expenditures
-1.16M -1.31M -1.47M -1.25M -613K -589K -865K -1.14M -1.29M -1.91M -5.68M -11.06M -13.81M -16.32M -14.99M -10.85M -9.82M -9.23M
Cash Acquisitions
65.39M 65.39M 65.39M 65.12M 66.36M 41.03M 41.03M -10.89M -123.71M -183.31M -183.31M -196.5M -84.93M n/a n/a n/a n/a n/a
Purchase of Investments
-132.06M -181.58M -261.71M -330.76M -435.48M -509.75M -511.7M -545.3M -470.62M -481.43M -467.91M -440.08M -679.82M -758.87M -960.69M -1.01B -971.79M -1.04B
Sales Maturities Of Investments
268.17M 285.21M 340.36M 431.75M 544.88M 627.31M 650.88M 694.19M 675.89M 746.3M 826.23M 897.16M 1.03B 1.1B 1.18B 1.2B 1.21B 1.36B
Other Investing Acitivies
-697K -697K n/a -65.12M -65.12M -39.79M -39.79M 65.86M 177.44M 237.03M 371.51M 457.08M 347.61M 338.91M 217.77M 186.17M 234.64M 318.14M
Investing Cash Flow
199.63M 167M 142.57M 99.74M 110.03M 118.22M 139.56M 162.19M 217.18M 276.15M 365.83M 446.02M 333.79M 322.6M 202.78M 175.32M 224.82M 308.9M
Debt Repayment
n/a n/a 15M 15M 15M 15M n/a n/a n/a n/a n/a n/a n/a n/a n/a 146.25M 146.25M 146.25M
Common Stock Repurchased
n/a n/a -3M -3M -3M -3M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
-2.92M -2.92M 27.09M 30M -34.92M -34.9M -64.9M -64.8M 121K 570K 1.51M 3.96M 7.62M 19.32M 36.24M 36.43M 34.3M -227.87M
Financial Cash Flow
314K 122K 42.12M 42.05M -22.89M -22.89M -64.89M -64.8M 121K 570K 1.51M 3.96M 7.62M 19.32M 36.24M 182.68M 180.55M -73.58M
Net Cash Flow
15.02M -9.9M 10.04M -33.67M -86.54M -91.95M -117.8M -105.76M -26.82M 8.96M 63.01M 51.74M -74.8M -82.17M -173.74M -1.83M 94.14M -76.87M
Free Cash Flow
-186.07M -178.19M -177.18M -177.81M -175.37M -189.17M -193.47M -204.4M -245.32M -269.4M -309.68M -408.9M -429.91M -440.31M -427.65M -370.6M -321.12M -321.53M